To develop a sensitive and practical diagnostic tool for early detection of autism spectrum disorder (ASD) using laser-induced breakdown spectroscopy (LIBS) to analyze metallomic profiles, which refer to the abundance of metals in biological samples.
Approach:
Key Findings:
Altered metallomic profiles in ASD patients may enable earlier and more accurate diagnosis, potentially transforming current diagnostic practices.
NELIBS has shown significant potential in intensifying LIBS signals, improving detection capabilities, which is essential for clinical application.
Initial results indicate over 100-fold signal enhancement using new nanoparticle methods, highlighting the technique's promise.
Interpretation:
The findings suggest that enhanced LIBS techniques could provide a non-invasive, portable, and cost-effective diagnostic tool for ASD, allowing for earlier intervention and more accurate differentiation from other neurological disorders, thereby improving patient care.
Limitations:
Challenges remain in standardizing NELIBS for routine clinical use, which could hinder its widespread adoption.
Further research is needed to fully understand and optimize the nanoparticle application, which is critical for ensuring reliability in clinical settings.
Conclusion:
The ELATED project aims to refine LIBS techniques to facilitate early ASD diagnosis, potentially transforming clinical practices and improving patient outcomes by enabling timely interventions.
